Aprea is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. The Company is pioneering a new approach to treat cancer by exploiting vulnerabilities associated with cancer cell mutations. This approach was developed to kill tumors while minimizing the effect on normal, healthy cells. Aprea’s technology has potential applications across multiple cancer types, enabling it to target a range of tumors, including ovarian, endometrial, colorectal and head and neck squamous cell carcinoma. The Company’s lead programs are APR-1051, an oral, small-molecule inhibitor of WEE1 kinase, and ATRN-119, a small molecule ATR inhibitor, both in clinical development for solid tumor indications.
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Aprea Therapeutics Inc market cap is $6.43M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aprea Therapeutics Inc 52 week high is $1.49 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aprea Therapeutics Inc 52 week low is $0.39 as of November 18, 2026.
Aprea Therapeutics Inc stock price today is $0.4649.
Aprea Therapeutics Inc stock price yesterday was $0.4531.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Aprea Therapeutics Inc's P/E ratio is -0.65.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Aprea Therapeutics Inc P/B ratio is 0.1885.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Aprea Therapeutics Inc 50-day moving average is $0.6097.